Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
According to Daniel J. Calvo, President of Cellomics, the collaboration objectives include a mix of applications and new product development, as well as establishing a key demonstration center for Europe. "Max Planck is a perfect partner for us," stated Calvo. "They have tremendous experience and capabilities in this area and their strong ties to key academic centers across Europe are a real plus. This collaboration will provide valuable input to help drive the development of our product and applications portfolio for the growing academic market."
As part of the Agreement, MPI-MCBG has purchased the Cellomics' ArrayScan(R) VTI HCS Reader along with its complete portfolio of BioApplications and HCi(TM) informatics software.
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.